{
    "code": "02023291",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023291",
    "time": "2019-11-08 03:03:09",
    "許可證字號": "衛署藥輸字第023291號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/10\/03",
    "發證日期": "90\/10\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202329105",
    "中文品名": "基利克膠囊100毫克",
    "英文品名": "GLIVEC CAPSULES 100MG",
    "適應症": "治療正值急性轉化期(BLAST CRISIS)、加速期或經ALPHA-干擾素治療無效之慢性期的慢性骨髓性白血病(CML)患者，治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷為慢性骨髓性白血病(CML)的病人。治療初診斷為費城染色體陽性急性淋巴性白血病（Ph+ ALL)且併用化療之成年及兒童患者。做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病(Ph+ ALL)之單一療法。治療患有與血小板衍生生長因子受體（PDGFR)基因重組相關之骨髓發育不全症候群(MDS)\/骨髓增生性疾病(MPD)之成人患者。治療患有系統性肥大細胞增生症(SM)，限具FIP1L1-PDGFR基因變異且不具有c-Kit基因D816V突變之成人患者。治療嗜伊紅性白血球增加症候群(HES)與或慢性嗜伊紅性白血病(CEL)且有血小板衍生生長因子受體(PDGFR)基因重組之成人患者。作為成人KIT(CD 117)陽性胃腸道基質瘤完全切除(complete gross resection)後之術後輔助治療。治療患有無法手術切除、復發性或轉移性且有血小板衍生生長因子受體(PDGFR)基因重組之隆突性皮膚纖維肉瘤(DFSP)之成人患者。",
    "劑型": "130膠囊劑",
    "包裝": "8-1000粒盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "IMATINIB MESYLATE",
    "主製造廠": {
        "申請商名稱": "0924601100  台灣諾華股份有限公司",
        "申請商地址": "台北市中山區民生東路三段2號8樓",
        "主製造廠": "",
        "製造廠名稱": "FCH0088000  NOVARTIS PHARMA STEIN AG"
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FCH0088200  NOVARTIS PHARMA AG",
            "製造廠廠址": "CH-4056 BASEL SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "公司"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000710",
            "成分名稱": "IMATINIB MESYLATE",
            "含量描述": "",
            "含量": "119.5000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "明黃橙\/明黃橙",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "長圓柱形",
        "標記一": "NVR",
        "標記二": "SI"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02023291.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023291&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Glivec Cap 100mg_TWI-211117_C-106-12-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023291&Seq=045&Type=9"
        },
        {
            "title": "Glivec Cap 100mg_TWI-211117_C-106-12-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023291&Seq=004&Type=9"
        },
        {
            "title": "Glivec Cap 100mg_TWI-130217_C-106-03-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023291&Seq=003&Type=9"
        },
        {
            "title": "Glivec Cap 100mg_package-104-12-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023291&Seq=001&Type=8"
        }
    ]
}